Sofpironium bromide indirectly reduces the rate of sweating by preventing the stimulation of acetylcholine receptors that are located on sweat glands. The Food and Drug Administration (FDA) has ...
Please provide your email address to receive an email when new articles are posted on . Hyperhidrosis, or excessive sweating, can occur on the underarms, palms, soles and face. Treatment options are ...
Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. Our bodies are incredible organisms, constantly at work to maintain a ...
Please provide your email address to receive an email when new articles are posted on . Sofdra (sofpironium) gel 12.45% is the first and only chemical entity for primary axillary hyperhidrosis. The ...
The FDA approved sofpironium topical gel 12.45% (Sofdra) for primary axillary hyperhidrosis, according to a statement from Botanix Pharmaceuticals. The approval stipulates use in adults and children 9 ...
Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...
(MENAFN- GetNews) The Key Axillary Hyperhidrosis Companies in the market include - Botanix Pharmaceuticals, Sound Surgical Technologies, LLC., Dr. August Wolff GmbH, Medy-Tox, Journey Medical ...
Hyperhidrosis is defined as excessive eccrine sweating that is quantitatively greater than that required for normal thermoregulation. It is a common problem seen by endocrinologists. At the 40th ...
Sofpironium bromide is a structural analogue of glycopyrrolate, an anticholinergic agent. Positive topline results were announced from 2 identical phase 3 studies evaluating sofpironium bromide in ...
Dee Anna Glaser, MD: Surgical options have probably fallen by the wayside now, with these newer treatments like botulinum toxins. We think about the old days, removing an entire axillary vault, some ...
Hyperhidrosis most commonly affects the armpits, followed by the palms of the hands and the soles of the feet. Impairment of quality of life differs based on where primary hyperhidrosis manifests on ...
MENLO PARK, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results